199 related articles for article (PubMed ID: 30562182)
1. The immune podocyte.
Bhargava R; Tsokos GC
Curr Opin Rheumatol; 2019 Mar; 31(2):167-174. PubMed ID: 30562182
[TBL] [Abstract][Full Text] [Related]
2. Immune podocytes in the immune microenvironment of lupus nephritis (Review).
Liu R; Wen X; Peng X; Zhao M; Mi L; Lei J; Xu K
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711069
[TBL] [Abstract][Full Text] [Related]
3. Another Piece of the Puzzle of Podocyte B7-1 Expression: Lupus Nephritis.
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Nephron; 2016; 133(2):129-38. PubMed ID: 27198457
[TBL] [Abstract][Full Text] [Related]
4. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
5. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
6. DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis.
Cai M; Zhou T; Wang X; Shang M; Zhang Y; Luo M; Xu C; Yuan W
Clin Exp Immunol; 2016 Mar; 183(3):317-25. PubMed ID: 26440060
[TBL] [Abstract][Full Text] [Related]
7. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
[TBL] [Abstract][Full Text] [Related]
8. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
9. Podocytes and autophagy: a potential therapeutic target in lupus nephritis.
Zhou XJ; Klionsky DJ; Zhang H
Autophagy; 2019 May; 15(5):908-912. PubMed ID: 30755075
[TBL] [Abstract][Full Text] [Related]
10. Podocyte involvement in human immune crescentic glomerulonephritis.
Bariéty J; Bruneval P; Meyrier A; Mandet C; Hill G; Jacquot C
Kidney Int; 2005 Sep; 68(3):1109-19. PubMed ID: 16105041
[TBL] [Abstract][Full Text] [Related]
11. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
[TBL] [Abstract][Full Text] [Related]
12. Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.
Bruschi M; Galetti M; Sinico RA; Moroni G; Bonanni A; Radice A; Tincani A; Pratesi F; Migliorini P; Murtas C; Franceschini F; Trezzi B; Brunini F; Gatti R; Tardanico R; Barbano G; Piaggio G; Messa P; Ravani P; Scolari F; Candiano G; Martini A; Allegri L; Ghiggeri GM
J Am Soc Nephrol; 2015 Aug; 26(8):1905-24. PubMed ID: 25398787
[TBL] [Abstract][Full Text] [Related]
13. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review.
Miziołek B; Bergler-Czop B; Stańkowska A; Brzezińska-Wcisło L
Cutan Ocul Toxicol; 2017 Mar; 36(1):77-84. PubMed ID: 27160965
[TBL] [Abstract][Full Text] [Related]
14. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
[TBL] [Abstract][Full Text] [Related]
15. The role of podocytes in lupus nephritis: Insights and implications.
Ichinose K
Clin Immunol; 2024 May; 262():110180. PubMed ID: 38462157
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches.
Dos Santos M; Poletti PT; Milhoransa P; Monticielo OA; Veronese FV
Semin Arthritis Rheum; 2017 Apr; 46(5):632-641. PubMed ID: 27839739
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype.
Zhang Z; Niu L; Tang X; Feng R; Yao G; Chen W; Li W; Feng X; Chen H; Sun L
Nephrol Dial Transplant; 2019 Apr; 34(4):597-605. PubMed ID: 29982691
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
[TBL] [Abstract][Full Text] [Related]
19. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.
Maeda K; Otomo K; Yoshida N; Abu-Asab MS; Ichinose K; Nishino T; Kono M; Ferretti A; Bhargava R; Maruyama S; Bickerton S; Fahmy TM; Tsokos MG; Tsokos GC
J Clin Invest; 2018 Aug; 128(8):3445-3459. PubMed ID: 29985166
[TBL] [Abstract][Full Text] [Related]
20. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
Jin J; Ye M; Zhao L; Zou W; Shen W; Zhang H; Gong J; He Q
Histol Histopathol; 2018 Aug; 33(8):803-814. PubMed ID: 29446059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
